Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the treatment of breast cancer to Roche's Genentech for an upfront cash payment ...

AI has the power to conduct these administrative tasks that pharmacists undertake. AI can help pharmacists intervene in a ...

Chiesi’s strategy aligns with EU priorities on innovation, security, and private R&D investment: the decision to establish a ...

The Securities & Exchange Commission (SEC) has accused Cassava's founder and former chief executive Remi Barbier and former ...

Rebecca Douglas is a strategic leader with a passion for nurturing talent. With an award-winning track record in developing ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibitor Actemra ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi ...

Read Deep Dive: Commercialisation in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical ...

Generative AI (GenAI) technology is already transforming everyday regulatory and safety processes, thanks to its ability to ...

One of the biggest market access stories this year has been the launch of Lilly Direct (and, subsequently, PfizerForAll .) ...

September is the perfect time to turn up the volume on conversations about Primary Biliary Cholangitis (PBC) and the symptoms ...